Journal
TRENDS IN MOLECULAR MEDICINE
Volume 23, Issue 6, Pages 563-576Publisher
ELSEVIER SCI LTD
DOI: 10.1016/j.molmed.2017.04.006
Keywords
-
Funding
- National Institute of Neurological Disorders and Stroke (NINDS) [1R01NS082257]
- National Institute on Aging (NIA) [1R01AG047231]
Ask authors/readers for more resources
Single-cell RNA sequencing (scRNA-seq) is an exciting new technology allowing the analysis of transcriptomes from individual cells, and is ideally suited to address the inherent complexity and dynamics of the central nervous system. scRNA-seq has already been applied to the study of molecular taxonomy of the brain. These works have paved the way to expanding our understanding of the nervous system and provide insights into cellular susceptibilities and molecular mechanisms in neurological and neurodegenerative diseases. We discuss recent progress and challenges in applying this technology to advance our understanding of the brain. We advocate the application of scRNA-seq in the discovery of targets and biomarkers as a new approach in developing novel therapeutics for the treatment of neurodegenerative diseases.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available